Home » Newsletters » BioWorld Science

BioWorld Science

April 25, 2022

View Archived Issues

EGFR-TKI TAS-3351 overcomes T790M and C797S mutations tied to NSCLC treatment resistance

CLN-978, a next-generation CD19-targeted therapeutic for the treatment of B-cell malignancies

Chinese investigators patent new THR-beta agonists

CJRS-10671 and CJRS-10672, biotherapeutic candidates with promising antitumor efficacy in vivo

Gilead Sciences discloses new HIV antivirals

Yonsei University presents new SLC26A4 inhibitors

Chinese researchers identify new anti-claudin18.2 ADCs

New HIF-2alpha PET tracer presented by University of Texas System

PAX8-SOX17 tandem involved in tumor angiogenesis

PKMYT1 targeting useful for the treatment of CCNE1-amplified cancers

Sex disparities of lupus recapitulated in mouse model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...